The efficacy and safety of Cefminox combined with Ambroxol hydrochloride in the treatment of senile community acquired pneumonia
Ren Yuzhe
Li Zhuying
Li Jing
Abstract：Objective To evaluate the efficacy and safety of Cefminox combined with Ambroxol hydrochloride in the treatment of senile community acquired pneumonia. Methods A total of 108 cases with senile community acquired pneumonia included in this study were dividing into control group and treatment group with each 54 cases. The patients in the both groups were give regular treatment. Patients in the control group were given Cefminox 100mg iv,bid,and patients in the treatment group revieved Cefminox 100mg iv,bid,and Ambroxol hydrochloride 30mg,iv,bid,7 days for a course and treated for 1 course. The serum PCT, CRP,NT-proBNP,cTnT-hs and adverse drug reactions were compared between the two groups. Results The clinical efficacy in treatment group was 96.30%,which significant higher than that in control group(81.48%)(P<0.05).The serum levels of PCT,CRP, NT-proBNP and cTnT-hs were all decreased after treatment. And the levels of PCT,CRP,NT-proBNP and cTnT-hs in treatment group were much lower than those in the control group(P<0.05).The adverse drug reactions were not statistically different between the two groups(P > 0.05). Conclusion Cefminox combined with Ambroxol hydrochloride in the treatment of senile community acquired pneumonia is effective with high safety.
Keywords：CefminoxAmbroxol hydrochlorideSenile community acquired pneumoniaClinical researchSafety
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 25-27 )